Bangladesh’s top pharma group & Serum Institute of India join hands for Covid-19 vaccine

The investment amount will be treated as an advance and once the
vaccine receives regulatory approvals, SII will include Bangladesh
among the countries who will be the first to receive an agreed
quantity of this vaccine from SII on a priority basis, according to a
press release.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bangladeshs-top-pharma-group-serum-institute-of-india-join-hands-for-covid-19-vaccine/articleshow/77802539.cms

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Right Tool for the Job: Foreign Policy Effectiveness and Nuclear Proliferation